
Splendora 5%60 ml
Square Pharmaceuticals PLC.
Minoxidil is used in two distinct forms with different approved indications: Oral Minoxidil (established, FDA-approved) Management of severe, symptomatic and more.
Minoxidil is used in two distinct forms with different approved indications:
Topical Minoxidil is not indicated for other causes of hair loss (e.g. postpartum hair loss, alopecia areata, scarring alopecia, or hair loss of unclear cause) and should not be used for these without prior medical evaluation.
| Population | Dosing |
|---|---|
| Adults | Initial dose 5 mg once daily. May be increased to 10 mg, 20 mg, then 40 mg per day at intervals of at least 3 days, as needed for blood pressure control. Usual effective dose range is 10–40 mg/day, given as a single dose or in two divided doses. Maximum dose: 100 mg/day. |
| Children (< 12 years) | Initial dose approximately 0.2 mg/kg once daily, increased gradually as needed under close specialist supervision. Maximum 50 mg/day. |
Oral Minoxidil must always be given concurrently with a diuretic (to control fluid retention) and a beta-blocker or other sympatholytic agent (to control reflex tachycardia); see Precautions and Warnings.
| Product | Dosing |
|---|---|
| 2% or 5% topical solution | Apply 1 mL to the affected area of a dry scalp twice daily (morning and evening), regardless of the size of the area involved. Do not exceed 2 mL/day. |
| 5% topical foam | Apply approximately half a capful to the affected area of a dry scalp twice daily. Do not exceed 1 capful/day. |
Apply only to the scalp; wash hands thoroughly after application. Continued twice-daily use is required to maintain any benefit — hair loss typically resumes within a few months of stopping treatment.
| Form | Common | Serious / less common |
|---|---|---|
| Oral | Fluid and sodium retention, weight gain, edema, tachycardia, palpitations, hypertrichosis (excessive growth of body/facial hair), breast tenderness | Pericardial effusion, cardiac tamponade (rare but serious), angina/worsening ischemic heart disease, congestive heart failure |
| Topical | Scalp itching, dryness, flaking, or irritation; contact dermatitis; initial temporary increase in hair shedding when starting treatment | Unwanted hair growth on the face or other skin areas if the product spreads beyond the scalp; rarely, chest pain, rapid heartbeat, dizziness, or swelling suggesting systemic absorption |
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.